Spotlight
Clinical
CME
Partners
FDA approves ISTA product, asked to evaluate another
On May 6 the FDA approved ISTA Pharmaceutical's new drug application (NDA) for lyophilized, ovine hyaluronidase for injection (Vitrase) for use as a spreading agent to facilitate the dispersion and absorption of other drugs.
Related Videos
Related Content
